Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Jeffrey Conn, P., Christopoulos, Arthur, Lindsley, Craig W.·2009·Nature Reviews Drug Discovery

DOI 10.1038/nrd2760

Cited by (1,000)

Items 401–500 of 1,000

Learning About Allosteric Drugs and Ways to Design Them
Zhen Wah Tan, Wei-Ven Tee, Igor N. Berezovsky · 2022 · Journal of Molecular Biology
Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein Gαo1 by the Ghrelin Receptor
Kirstie A. Bennett, Christopher J. Langmead, Alan Wise, Graeme Milligan · 2009 · Molecular Pharmacology
Pharmacological Characterization of LY593093, an M1 Muscarinic Acetylcholine Receptor-Selective Partial Orthosteric Agonist
Marla L. Watt, Douglas A. Schober, Stephen A. Hitchcock, Bin Liu, Amy K. Chesterfield, David L. McKinzie, Christian C. Felder · 2011 · Journal of Pharmacology and Experimental Therapeutics
Sweet Taste Receptor Gene Variation and Aspartame Taste in Primates and Other Species
X. Li, Alexander A. Bachmanov, Kenji Maehashi, W. Li, R. K. S. Lim, Joseph G. Brand, Gary K. Beauchamp, Danielle R. Reed, Chloe Thai, Wely Brasil Floriano · 2011 · Chemical Senses
Metabotropic glutamate receptor subtype 7 in the bed nucleus of the stria terminalis is essential for intermale aggression
Masugi-Tokita, Miwako, Flor, Peter J, Kawata, Mitsuhiro · 2016 · Neuropsychopharmacology
Metabotropic Glutamate Receptors for New Treatments in Schizophrenia
E. J. Herman, Michael Bubser, Peter Jeffrey Conn, Carrie K. Jones · 2012 · Handbook of experimental pharmacology
Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors
Elisa Alvarez‐Curto, John Daniel Pediani, Graeme Milligan · 2010 · Analytical and Bioanalytical Chemistry
Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor
Susmith Mukund, Yonglei Shang, Holly J. Clarke, Azadeh Madjidi, Jacob E. Corn, Lance Kates, Ganesh A. Kolumam, Vicky Chiang, Elizabeth Luis, Jeremy M. Murray et al. · 2013 · Journal of Biological Chemistry
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
Jaimini Cegla, Ben J. Jones, James Gardiner, David J. Hodson, Thomas Marjot, Emma Rose McGlone, Tricia Tan, Stephen Robert Bloom · 2017 · Endocrinology
Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway
Yohn, Samantha E., Galbraith, Jordan, Calipari, Erin S., Conn, P. Jeffrey · 2019 · ACS Chemical Neuroscience
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia
Susan F. Sonnenschein, Anthony A. Grace · 2019 · Neuropharmacology
Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs.
Gregory J. Digby, Peter Jeffrey Conn, Craig W. Lindsley · 2010 · PubMed
Mapping the allosteric sites of the A2A adenosine receptor
Alisha D. Caliman, Yinglong Miao, James Andrew McCammon · 2017 · Chemical Biology & Drug Design
Peptide Inhibitors Disrupt the Serotonin 5-HT2CReceptor Interaction with Phosphatase and Tensin Homolog to Allosterically Modulate Cellular Signaling and Behavior
Noelle C. Anastasio, Scott R. Gilbertson, Marcy J. Bubar, Anton Agarkov, Sonja J. Stutz, Yow‐Jiun Jeng, Nicole M. Bremer, Thressa D. Smith, Robert G. Fox, Sarah E. Swinford-Jackson et al. · 2013 · Journal of Neuroscience
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics
Adam G. Walker, Peter Jeffrey Conn · 2014 · Current Opinion in Pharmacology
Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABAB Receptor
Claudia Mugnaini, Valentina Pedani, Angelo Casu, Carla Lobina, Alberto Casti, Paola Maccioni, Alessandra Porcu, Daniela Giunta, Stefania Lamponi, Maurizio Solinas et al. · 2013 · Journal of Medicinal Chemistry
Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature
Craig W. Lindsley, Corey R. Hopkins · 2012 · Expert Opinion on Therapeutic Patents
Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor
Peter Keov, Céline Valant, Shane M. Devine, J. Robert Lane, Peter J. Scammells, Patrick Michael Sexton, Arthur Christopoulos · 2013 · Molecular Pharmacology
State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 – Relation to antipsychotic-like drug effects
Robert W. Gould, Michael T. Nedelcovych, Xuewen Gong, Erica Tsai, Michael Bubser, Thomas M. Bridges, Michael R. Wood, Mark E. Duggan, Nicholas J. Brandon, John Dunlop et al. · 2015 · Neuropharmacology
The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
Mario Rossi, Irene Fasciani, Francesco Marampon, Roberto Maggio, Marco Scarselli · 2017 · Molecular Pharmacology
G-protein–coupled receptors are dynamic regulators of digestion and targets for digestive diseases
Canals, Meritxell, Poole, Daniel P., Veldhuis, Nicholas A., Schmidt, Brian L., Bunnett, Nigel W. · 2019 · Gastroenterology
Bitter-Tasting Amino Acids l -Arginine and l -Isoleucine Differentially Regulate Proton Secretion via T2R1 Signaling in Human Parietal Cells in Culture
Verena Stoeger, Ann‐Katrin Holik, Kathrin Hölz, Tamir Dingjan, Joachim Hans, Jakob Peter Ley, Gerhard E. Krammer, Masha Y. Niv, Mark Manuel Somoza, Veronika Somoza · 2019 · Journal of Agricultural and Food Chemistry
Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations
Matteo Carli, Giulia Sormani, Álex Rodríguez, Alessandro Laio · 2020 · The Journal of Physical Chemistry Letters
Engineering an Allosteric Control of Protein Function
Yashavantha L. Vishweshwaraiah, Jiaxing Chen, Nikolay V. Dokholyan · 2021 · The Journal of Physical Chemistry B
Agonist Dynamics and Conformational Selection during Microsecond Simulations of the A2A Adenosine Receptor
Ji Young Lee, Edward R. Lyman · 2012 · Biophysical Journal
Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors
Zhiwei Feng, Guanxing Hu, Shifan Ma, Xiang‐Qun Xie · 2015 · The AAPS Journal
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Andrew B. Tobin · 2024 · Nature Reviews Drug Discovery
VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
Hilary Highfield Nickols, Joannes P. Yuh, Karen J. Gregory, Ryan D. Morrison, Brittney S. Bates, Shaun R. Stauffer, Kyle A. Emmitte, Michael Bubser, Weimin Peng, Michael T. Nedelcovych et al. · 2015 · Journal of Pharmacology and Experimental Therapeutics
N-Heterocyclic derived M1 positive allosteric modulators
Scott D. Kuduk, Christina Ng Di Marco, Victoria Cofre, Daniel R. Pitts, William J. Ray, Lei Ma, Marion Wittmann, Lone Veng, Matthew A. Seager, Kenneth A. Koeplinger et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
Novel M1allosteric ligands: a patent review
Scott D. Kuduk, Douglas C. Beshore · 2012 · Expert Opinion on Therapeutic Patents
Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist
Stefanie Dedeurwaerdere, Cindy Wintmolders, Roel Straetemans, Darrel J. Pemberton, Xavier Langlois · 2010 · Psychopharmacology
Formyl Peptide Receptors in Mice and Men: Similarities and Differences in Recognition of Conventional Ligands and Modulating Lipopeptides
Malene Winther, Cláes Dahlgren, Huamei Fu Forsman · 2017 · Basic & Clinical Pharmacology & Toxicology
Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor
Haiyi Chen, Weitao Fu, Zhe Wang, Xuwen Wang, Tailong Lei, Feng Zhu, Dan Li, Shan Chang, Lei Xu, Tingjun Hou · 2018 · ACS Chemical Neuroscience
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Samantha E. Yohn, P.D. Harvey, Stephen K. Brannan, William P. Horan · 2024 · Frontiers in Psychiatry
Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy
Hiroaki Kume, Kentaro Fukunaga, Tetsuya Oguma · 2015 · Pharmacology & Therapeutics
Metabotropic glutamate receptors and drug addiction
Richard M. Cleva, Michael Foster Olive · 2012 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
Custom-designed proteins as novel therapeutic tools? The case of arrestins
Vsevolod V. Gurevich, Eugenia V. Gurevich · 2010 · Expert Reviews in Molecular Medicine
Emerging concepts and approaches for chemokine-receptor drug discovery
Morgan O’Hayre, Catherina L. Salanga, Tracy M. Handel, Damon J. Hamel · 2010 · Expert Opinion on Drug Discovery
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety
Andrew S. Felts, Alice L. Rodriguez, Ryan D. Morrison, Daryl F. Venable, Jason T. Manka, Brittney S. Bates, Anna Louise Blobaum, Frank W. Byers, John Scott Daniels, Colleen Marie Niswender et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites
Craig W. Lindsley · 2014 · Journal of Medicinal Chemistry
Molecular mechanism of the wake-promoting agent TAK-925
Jie Yin, Yanyong Kang, Aaron P. McGrath, Karen Chapman, Megan Sjodt, Eiji Kimura, Atsutoshi Okabe, Tatsuki Koike, Yuhei Miyanohana, Yūji Shimizu et al. · 2022 · Nature Communications
Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease
Hugh Hiu Nam Chan, Helen Paur, Anthony Christopher Vernon, Virginia Zabarsky, Krishna P. Datla, Martin J. Croucher, David Trevor Dexter · 2010 · Parkinson s Disease
Towards the miniaturization of GPCR-based live-cell screening assays
S. A. M. Martins, João R. C. Trabuco, Gabriel Amaro Monteiro, Virginia Chu, João Pedro Conde, D.M.F. Prazeres · 2012 · Trends in biotechnology
Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions
Milt Teitler, Nicole Toohey, Jessica A. Knight, Michael T. Klein, Carol Smith · 2010 · Psychopharmacology
Muscarinic Pain Pharmacology: Realizing the Promise of Novel Analgesics by Overcoming Old Challenges
Dennis F. Fiorino, Miguel García‐Guzmán · 2011 · Handbook of experimental pharmacology
Structure and function of G protein‐coupled receptor oligomers: implications for drug discovery
Nicole Star Schonenbach, Sunyia Hussain, Michelle Ann O'Malley · 2014 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators
Thomas M. Bridges, J. Phillip Kennedy, Corey R. Hopkins, Peter Jeffrey Conn, Craig W. Lindsley · 2010 · Bioorganic & Medicinal Chemistry Letters
Beyond Dopamine: Glutamate as a Target for Future Antipsychotics
Kyra-Verena Sendt, Giovanni Giaroli, Derek Kenneth Tracy · 2012 · ISRN Pharmacology
Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4)
Emery W. Smith, Peter S. Chase, Colleen Marie Niswender, Thomas J. Utley, Douglas J. Sheffler, Meredith J. Noetzel, Atin Lamsal, Michael R. Wood, Peter Jeffrey Conn, Craig W. Lindsley et al. · 2015 · SLAS DISCOVERY
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators
Alice E. Berizzi, Patrick R. Gentry, Patricia Rueda, Sandra den Hoedt, Patrick Michael Sexton, Christopher J. Langmead, Arthur Christopoulos · 2016 · Molecular Pharmacology
Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5
Yuemin Bian, Zhiwei Feng, Peng Yang, Xiang‐Qun Xie · 2017 · The AAPS Journal
mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice
Kaziya M. Lee, Michal A. Coelho, MacKayla A. Class, Karen Kathleen Szumlinski · 2018 · Drug and Alcohol Dependence
Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators
Daniel E. O’Brien, Douglas M. Shaw, Hyekyung P. Cho, Alan J. Cross, Steven S. Wesolowski, Andrew S. Felts, Jonas Bergare, Charles S. Elmore, Craig W. Lindsley, Colleen Marie Niswender et al. · 2018 · Molecular Pharmacology
Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling
Edin Muratspahić, Nataša Tomašević, Shahrooz Nasrollahi-Shirazi, Jasmin Gattringer, Fabiola Susanna Emser, Michael Freissmuth, Christian W. Gruber · 2021 · Journal of Natural Products
Concerted conformational changes control metabotropic glutamate receptor activity
Nathalie Lecat‐Guillet, Robert B. Quast, Hongkang Liu, Emmanuel Bourrier, Thor Christian Møller, Xavier Rovira, Stéphanie Soldevila, Laurent Lamarque, Eric Trinquet, Jianfeng Liu et al. · 2023 · Science Advances
Carboxypeptidase M Is a Positive Allosteric Modulator of the Kinin B1 Receptor
Xianming Zhang, Fulong Tan, Randal A. Skidgel · 2013 · Journal of Biological Chemistry
mGluR5: Exploration of Orthosteric and Allosteric Ligand Binding Pockets and Their Applications to Drug Discovery
Christina Mølck, Kasper Harpsøe, David E.I. Gloriam, Jesper Mosolff Mathiesen, Søren Møller Nielsen, Hans Bräuner‐Osborne · 2014 · Neurochemical Research
Group II Metabotropic Glutamate Receptor Agonist LY379268 Regulates AMPA Receptor Trafficking in Prefrontal Cortical Neurons
Min-Juan Wang, Yanchun Li, Melissa A. Snyder, Huaixing Wang, Feng Li, Wen‐Jun Gao · 2013 · PLoS ONE
Allosteric Modulation of K v 11.1 (hERG) Channels Protects Against Drug-Induced Ventricular Arrhythmias
Zhiyi Yu, Jia Liu, Jacobus P. D. van Veldhoven, Adriaan P. IJzerman, Martin Jan Schalij, Daniël A. Pijnappels, Laura H. Heitman, Antoine A.F. de Vries · 2016 · Circulation Arrhythmia and Electrophysiology
Vibrational resonance, allostery, and activation in rhodopsin-like G protein-coupled receptors
Kristina N. Woods, Jürgen Pfeffer, Arpana Dutta, Judith Klein‐Seetharaman · 2016 · Scientific Reports
Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Marco Carli, Shivakumar Kolachalam, Stefano Aringhieri, Mario Rossi, Luca Giovannini, Roberto Maggio, Marco Scarselli · 2017 · Current Neuropharmacology
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D 2 receptor
Christopher J. Draper-Joyce, Mayako Michino, Ravi Kumar Verma, Carmen Klein Herenbrink, Jeremy Shonberg, Anitha Kopinathan, Peter J. Scammells, Ben Capuano, David M. Thal, Jonathan A. Javitch et al. · 2018 · Biochemical Pharmacology
An Approach to Discovering Novel Muscarinic M1 Receptor Positive Allosteric Modulators with Potent Cognitive Improvement and Minimized Gastrointestinal Dysfunction
Kurimoto, Emi, Matsuda, Satoru, Shimizu, Yuji, Sako, Yuu, Mandai, Takao, Sugimoto, Takahiro, Sakamoto, Hiroki, Kimura, Haruhide · 2018 · The Journal of Pharmacology and Experimental Therapeutics
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells
Claudia Volpi, Giada Mondanelli, Maria Teresa Pallotta, Carmine Vacca, Alberta Iacono, Marco Gargaro, Elisa Albini, Roberta Bianchi, Maria Laura Belladonna, Sylvain Célanire et al. · 2015 · Neuropharmacology
ETA-receptor antagonists or allosteric modulators?
Jo G. R. De Mey, Matthijs G. Compeer, Pieter Lemkens, Merlijn J. P. M. T. Meens · 2011 · Trends in Pharmacological Sciences
Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries
Yuemin Bian, Xiang‐Qun Xie · 2022 · Cells
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs
Peter Obi, Senthil Natesan · 2022 · Journal of Medicinal Chemistry
Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer as 5-HT2CReceptor Allosteric Modulators
Chunyong Ding, Nicole M. Bremer, Thressa D. Smith, Patricia K. Seitz, Noelle C. Anastasio, Kathryn A. Cunningham, Jia Zhou · 2012 · ACS Chemical Neuroscience
Scientific process, pharmacology and drug discovery
David G. Trist · 2011 · Current Opinion in Pharmacology
Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
Antonio Carrieri, Violeta I. Pérez‐Nueno, Giovanni Lentini, David W. Ritchie · 2013 · Current Topics in Medicinal Chemistry
Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box
Hong Huang, Andrew P. Degnan, Anand Balakrishnan, Amy E. Easton, Michael Gulianello, Yanling Huang, Michele Matchett, Gail K. Mattson, Regina Miller, Kenneth S. Santone et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes
Sophie J. Bradley, Colin Molloy, Christoffer Bundgaard, Adrian J. Mogg, Karen J Thompson, Louis Dwomoh, Helen Sanger, Michael Crabtree, Simon M. Brooke, Patrick Michael Sexton et al. · 2018 · Molecular Pharmacology
Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach
Bethany A. Falls, Yan Zhang · 2018 · ACS Chemical Neuroscience
Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery
Yuemin Bian, Jaden Jungho Jun, Jacob Cuyler, Xiang‐Qun Xie · 2020 · European Journal of Medicinal Chemistry
Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats
A. A. Bakhtyukov, Kira Viktorovna Derkach, Maxim Gureev, Dmitry Viktorovich Dar’in, V. N. Sorokoumov, Irina V. Romanova, Irina Yu. Morina, Anna M. Stepochkina, Alexander Olegovich Shpakov · 2020 · International Journal of Molecular Sciences
The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
Kanika Singh, Nazim Nassar, Ava Bachari, Ellen Schanknecht, Srinivasa Reddy Telukutla, Roby Zomer, Terrence J. Piva, Nitin L. Mantri · 2021 · Cancers
The Emerging Role of Promiscuous 7TM Receptors as Chemosensors for Food Intake
Petrine Wellendorph, Lars Dan Johansen, Hans Bräuner‐Osborne · 2010 · Vitamins and hormones
The GABABreceptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice
Joanna Monika Wierońska, Magdalena Kusek, Krzysztof Tokarski, J. Wabno, Wolfgang Froestl, Andrzej Pilc · 2011 · British Journal of Pharmacology
In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)
Elisabetta Perdonà, Vivian J. A. Costantini, Michela Tessari, Prisca Martinelli, Corrado Carignani, Enzo Valerio, M. H. Selina Mok, Laura Zonzini, Filippo Visentini, Massimo Gianotti et al. · 2011 · Neuropharmacology
Consideration of allosterism and interacting proteins in the physiological functions of the serotonin transporter
Huailing Zhong, Connie Sánchez, Marc G. Caron · 2011 · Biochemical Pharmacology
Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications
János Galambos, Attila Bielik, Mikhail Krasavin, Zoltán Orgován, György Domány, Katalin Nógrádi, Gábor Wágner, György Tibor Balogh, Zoltán Béni, János Kóti et al. · 2017 · Journal of Medicinal Chemistry
Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease
Daniela Volpato, Ulrike Holzgrabe · 2018 · Molecules
Study of Functional and Allosteric Sites in Protein Superfamilies
Dmitry A. Suplatov, Vytas K. Švedas · 2015 · Acta Naturae
In silicomapping of allosteric ligand binding sites in type‐1 cannabinoid receptor
Annalaura Sabatucci, Daniel Tortolani, Enrico Dainese, Mauro Maccarrone · 2017 · Biotechnology and Applied Biochemistry
Muscarinic M 4 and M 5 receptors in the ventral subiculum differentially modulate alcohol seeking versus consumption in male alcohol‐preferring rats
Leigh C. Walker, Kate L. Huckstep, Nicola A. Chen, Lexi J. Hand, Craig W. Lindsley, Christopher J. Langmead, Andrew John Lawrence · 2021 · British Journal of Pharmacology
The In Vivo Effects of the CB 1 -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex J. Straiker, Pushkar M. Kulkarni, Roger G. Pertwee, Ganesh A. Thakur, William H. Baldridge, Melanie E.M. Kelly · 2017 · Journal of Ocular Pharmacology and Therapeutics
Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Daniel Eric Felsing, Manish Kumar Jain, John Allen · 2019 · Current Topics in Medicinal Chemistry
Exploration of Allosteric Agonism Structure–Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)
Mark Turlington, Meredith J. Noetzel, Aspen C. Chun, Ya Zhou, Rocco D. Gogliotti, Elizabeth Dong Nguyen, Karen J. Gregory, Paige N. Vinson, Jerri M. Rook, Kiran K. Gogi et al. · 2013 · Journal of Medicinal Chemistry
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M 2 Muscarinic Acetylcholine Receptor
Andrea Pegoli, Xueke She, David Wifling, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller · 2017 · Journal of Medicinal Chemistry
Modulation of NMDA receptor function as a treatment for schizophrenia
Christopher L. Cioffi · 2013 · Bioorganic & Medicinal Chemistry Letters
Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators
Eunhee Chae, Yongje Shin, Eun-Ju Ryu, Mi Kyung Ji, Nahm Ryune Cho, Kiho Lee, Hyun Ji Jeong, Soo-Jin Kim, Yeonjung Choi, Kyung Seok Oh et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
Toward an understanding of the sequence and structural basis of allosteric proteins
Xiao‐Bai Li, Yingyi Chen, Shaoyong Lu, Zhimin Huang, Xinyi Liu, Qi Wang, Ting Shi, Jian Zhang · 2013 · Journal of Molecular Graphics and Modelling
Direct coupling of detergent purified human mGlu5 receptor to the heterotrimeric G proteins Gq and Gs
Chady Nasrallah, Karine Rottier, Romain Marcelin, Vincent Compan, Joan Font, Amadeu Llebaria, Jean‐Philippe Pin, Jean‐Louis Banères, Guillaume Lebon · 2018 · Scientific Reports
Are there physicochemical differences between allosteric and competitive ligands?
Smith, Richard D., Lu, Jing, Carlson, Heather A. · 2017 · PLOS Computational Biology
Investigational medications for treatment of patients with Alzheimer disease.
Pamela E. Potter · 2010 · PubMed
4-Aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators
Hui Xiong, Todd A. Brugel, Michael Balestra, Dean G. Brown, Kelly A. Brush, Caprice Hightower, Lindsay Hinkley, Valerie Hoesch, James J. Kang, Gerard M. Koether et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
GABAB Receptor-Positive Modulators: Brain Region-Dependent Effects
Julie G. Hensler, Tushar Advani, Teresa F. Burke, Kejun Cheng, Kenner C. Rice, Wouter Koek · 2011 · Journal of Pharmacology and Experimental Therapeutics
CB1 allosteric modulators and their therapeutic potential in CNS disorders
Catharine A. Mielnik, Vincent M. Lam, Ruth A. Ross · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers
Khuraijam Dhanachandra Singh, Zaira Palomino Jara, Terri J. Harford, Prasenjit Prasad Saha, Triveni R. Pardhi, Russell W. Desnoyer, Sadashiva S. Karnik · 2021 · Proceedings of the National Academy of Sciences
Preventing incubation of drug craving to treat drug relapse: from bench to bedside
Xiaoxing Liu, Kai Yuan, Tangsheng Lu, Xiao Lin, Wei Zheng, Yan-Xue Xue, Jie Shi, Lin Lü, Ying Han · 2023 · Molecular Psychiatry